In this study, we perform functional genomics assays in glioblastoma and non-small cell lung cancer in vitro models to understand how changes in GPC4 expression affect cancer proliferation, revealing divergent cancer type-dependent effects on proliferation. This evidence concerns the gene GPC4 and non-small cell lung carcinoma.